| cellular amide metabolic process | GO:0043603 | 58 | 0.979 | |
| oxidation reduction process | GO:0055114 | 342 | 0.970 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.954 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.885 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.768 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.738 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.729 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.720 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.711 | |
| peptide metabolic process | GO:0006518 | 46 | 0.702 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.700 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.677 | |
| glutathione metabolic process | GO:0006749 | 16 | 0.649 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.642 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.605 | |
| lipid catabolic process | GO:0016042 | 69 | 0.583 | |
| toxin catabolic process | GO:0009407 | 1 | 0.570 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.510 | |
| xenobiotic catabolic process | GO:0042178 | 1 | 0.487 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.442 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.390 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.379 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.373 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.350 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.341 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.339 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.291 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.289 | |
| negative regulation of nitric oxide synthase biosynthetic process | GO:0051771 | 1 | 0.287 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.286 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.261 | |
| sterol metabolic process | GO:0016125 | 58 | 0.258 | Mouse |
| regulation of phagocytosis | GO:0050764 | 33 | 0.255 | |
| response to acid chemical | GO:0001101 | 111 | 0.229 | |
| organic heteropentacyclic compound catabolic process | GO:1901377 | 1 | 0.227 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.223 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.217 | |
| lipid modification | GO:0030258 | 65 | 0.201 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.191 | |
| positive regulation of t cell mediated cytotoxicity | GO:0001916 | 15 | 0.185 | |
| response to metal ion | GO:0010038 | 47 | 0.184 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.184 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.174 | |
| secondary metabolite catabolic process | GO:0090487 | 1 | 0.172 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.168 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.166 | |
| protein activation cascade | GO:0072376 | 19 | 0.165 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.165 | Mouse |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.155 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.153 | |
| male gamete generation | GO:0048232 | 285 | 0.148 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.147 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.143 | |
| nadph regeneration | GO:0006740 | 2 | 0.143 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.143 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.141 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.139 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.137 | |
| response to oxidative stress | GO:0006979 | 123 | 0.136 | |
| lipid localization | GO:0010876 | 126 | 0.133 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.132 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.126 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.121 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.118 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.116 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.115 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.110 | |
| spermatogenesis | GO:0007283 | 284 | 0.110 | |
| response to steroid hormone | GO:0048545 | 56 | 0.102 | |
| benzene containing compound metabolic process | GO:0042537 | 5 | 0.102 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.098 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.097 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.096 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.095 | |
| cholesterol storage | GO:0010878 | 4 | 0.092 | |
| aflatoxin catabolic process | GO:0046223 | 1 | 0.089 | |
| regulation of phospholipid catabolic process | GO:0060696 | 2 | 0.087 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.084 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.083 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.082 | |
| lipid oxidation | GO:0034440 | 29 | 0.081 | |
| sterol homeostasis | GO:0055092 | 45 | 0.079 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.078 | |
| immune effector process | GO:0002252 | 321 | 0.078 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.077 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.075 | Mouse |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.075 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.073 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.073 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.072 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.071 | |
| coagulation | GO:0050817 | 78 | 0.070 | |
| heart morphogenesis | GO:0003007 | 178 | 0.066 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.066 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.065 | |
| glucan metabolic process | GO:0044042 | 32 | 0.065 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.064 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.064 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.064 | |
| cell adhesion | GO:0007155 | 329 | 0.063 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.063 | |
| toxin metabolic process | GO:0009404 | 5 | 0.063 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.062 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.062 | |
| monocyte chemotactic protein 1 production | GO:0071605 | 1 | 0.062 | |
| response to peptide hormone | GO:0043434 | 127 | 0.062 | |
| phagocytosis | GO:0006909 | 66 | 0.061 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.060 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.058 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.058 | |
| response to inorganic substance | GO:0010035 | 96 | 0.058 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.057 | |
| cellular homeostasis | GO:0019725 | 240 | 0.056 | |
| response to hydroperoxide | GO:0033194 | 6 | 0.056 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.056 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.056 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.055 | |
| sterol catabolic process | GO:0016127 | 5 | 0.055 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.054 | |
| regulation of protein activation cascade | GO:2000257 | 7 | 0.054 | |
| response to alcohol | GO:0097305 | 48 | 0.053 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.053 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.052 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.052 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.051 | |
| response to monosaccharide | GO:0034284 | 67 | 0.050 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.050 | |
| protein processing | GO:0016485 | 163 | 0.050 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.050 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.049 | |
| adaptive immune response | GO:0002250 | 155 | 0.049 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.048 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.047 | |
| organ regeneration | GO:0031100 | 2 | 0.047 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.047 | |
| response to testosterone | GO:0033574 | 3 | 0.047 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.047 | |
| response to peptide | GO:1901652 | 136 | 0.047 | |
| negative regulation of monocyte chemotactic protein 1 production | GO:0071638 | 1 | 0.047 | |
| skeletal system development | GO:0001501 | 356 | 0.046 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.046 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.046 | |
| endocytosis | GO:0006897 | 168 | 0.045 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.045 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.045 | |
| aspartate family amino acid metabolic process | GO:0009066 | 10 | 0.044 | |
| hexose catabolic process | GO:0019320 | 3 | 0.044 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.044 | |
| response to nutrient levels | GO:0031667 | 109 | 0.043 | |
| liver development | GO:0001889 | 66 | 0.043 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.043 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.043 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.042 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.042 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.041 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.041 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.040 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.040 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.040 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.040 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.040 | |
| regulation of cell activation | GO:0050865 | 289 | 0.039 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.039 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.039 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.039 | |
| regulation of complement activation | GO:0030449 | 7 | 0.038 | |
| positive regulation of sterol transport | GO:0032373 | 9 | 0.038 | |
| positive regulation of mitochondrial calcium ion concentration | GO:0051561 | 3 | 0.038 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.038 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.038 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.038 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.037 | |
| urogenital system development | GO:0001655 | 261 | 0.037 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.037 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.037 | |
| lung development | GO:0030324 | 164 | 0.037 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.037 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.037 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.036 | |
| t cell activation | GO:0042110 | 289 | 0.036 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.035 | |
| sterol transport | GO:0015918 | 38 | 0.035 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.035 | |
| short chain fatty acid metabolic process | GO:0046459 | 6 | 0.035 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.035 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.035 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.034 | |
| t cell differentiation | GO:0030217 | 174 | 0.033 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.033 | |
| maintenance of location | GO:0051235 | 89 | 0.033 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.032 | Mouse |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.032 | |
| response to oxygen radical | GO:0000305 | 16 | 0.032 | |
| hydrogen peroxide catabolic process | GO:0042744 | 5 | 0.032 | |
| spermatid differentiation | GO:0048515 | 115 | 0.032 | |
| protein maturation | GO:0051604 | 176 | 0.032 | |
| very long chain fatty acid metabolic process | GO:0000038 | 8 | 0.032 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.032 | |
| multicellular organism growth | GO:0035264 | 161 | 0.032 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.032 | |
| gland development | GO:0048732 | 330 | 0.032 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | |
| glycosylation | GO:0070085 | 62 | 0.031 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.031 | |
| regulation of coagulation | GO:0050818 | 31 | 0.031 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.031 | |
| innate immune response | GO:0045087 | 157 | 0.031 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.030 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.030 | |
| lipid storage | GO:0019915 | 36 | 0.030 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.030 | |
| blood coagulation | GO:0007596 | 76 | 0.030 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.029 | |
| hydrogen peroxide metabolic process | GO:0042743 | 16 | 0.029 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.029 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.029 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.028 | |
| steroid metabolic process | GO:0008202 | 119 | 0.028 | Mouse |
| pentose phosphate shunt | GO:0006098 | 2 | 0.028 | |
| response to stilbenoid | GO:0035634 | 22 | 0.028 | |
| aflatoxin metabolic process | GO:0046222 | 1 | 0.027 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.027 | |
| positive regulation of steroid biosynthetic process | GO:0010893 | 4 | 0.027 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.027 | |
| epithelial cell development | GO:0002064 | 159 | 0.027 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.027 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.026 | |
| cell killing | GO:0001906 | 67 | 0.026 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.026 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.026 | |
| iron ion transport | GO:0006826 | 17 | 0.026 | |
| protein oligomerization | GO:0051259 | 67 | 0.026 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.026 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| positive regulation of myeloid leukocyte mediated immunity | GO:0002888 | 14 | 0.025 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.025 | |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.025 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.025 | |
| amide transport | GO:0042886 | 138 | 0.025 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.025 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.025 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.025 | |
| negative regulation of peroxidase activity | GO:2000469 | 1 | 0.024 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.024 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.024 | |
| regulation of protein stability | GO:0031647 | 52 | 0.024 | |
| retina homeostasis | GO:0001895 | 23 | 0.024 | |
| secondary metabolic process | GO:0019748 | 18 | 0.024 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.024 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.024 | |
| glucose catabolic process | GO:0006007 | 3 | 0.023 | |
| defense response to bacterium | GO:0042742 | 119 | 0.023 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway | GO:0002484 | 3 | 0.023 | |
| wound healing | GO:0042060 | 157 | 0.023 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.023 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.023 | |
| prostaglandin metabolic process | GO:0006693 | 11 | 0.023 | |
| response to superoxide | GO:0000303 | 16 | 0.023 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.022 | |
| glucose homeostasis | GO:0042593 | 128 | 0.022 | |
| phospholipid catabolic process | GO:0009395 | 5 | 0.022 | |
| gonad development | GO:0008406 | 141 | 0.022 | |
| cellular response to testosterone stimulus | GO:0071394 | 1 | 0.022 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.022 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.022 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.022 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.022 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.021 | |
| cellular response to food | GO:0071240 | 1 | 0.021 | |
| kidney development | GO:0001822 | 213 | 0.021 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.021 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.021 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.021 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.020 | |
| nuclear transport | GO:0051169 | 139 | 0.020 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.020 | |
| dicarboxylic acid metabolic process | GO:0043648 | 18 | 0.020 | |
| protein glycosylation | GO:0006486 | 55 | 0.020 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.020 | |
| amine metabolic process | GO:0009308 | 45 | 0.020 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.020 | |
| respiratory system development | GO:0060541 | 190 | 0.020 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.020 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.020 | |
| intracellular sterol transport | GO:0032366 | 3 | 0.020 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.019 | |
| cellular response to bacterial lipopeptide | GO:0071221 | 3 | 0.019 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.019 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.019 | |
| glycolytic process | GO:0006096 | 20 | 0.019 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 4 | 0.019 | |
| mitochondrial calcium ion homeostasis | GO:0051560 | 7 | 0.019 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.019 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.019 | |
| mapk cascade | GO:0000165 | 281 | 0.019 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.018 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.018 | |
| regulation of defense response | GO:0031347 | 233 | 0.018 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.018 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.018 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.018 | |
| cation transport | GO:0006812 | 399 | 0.018 | |
| cellular response to starvation | GO:0009267 | 57 | 0.018 | |
| male sex differentiation | GO:0046661 | 109 | 0.018 | |
| positive regulation of proteolysis involved in cellular protein catabolic process | GO:1903052 | 31 | 0.018 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.018 | |
| acute inflammatory response to antigenic stimulus | GO:0002438 | 12 | 0.018 | |
| endoplasmic reticulum calcium ion homeostasis | GO:0032469 | 11 | 0.018 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.018 | |
| positive regulation of complement activation | GO:0045917 | 2 | 0.018 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.017 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.017 | |
| cellular response to hydroperoxide | GO:0071447 | 4 | 0.017 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.017 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.017 | |
| lipoprotein transport | GO:0042953 | 7 | 0.017 | |
| protein folding | GO:0006457 | 28 | 0.017 | |
| intracellular lipid transport | GO:0032365 | 3 | 0.017 | |
| regulation of type ii hypersensitivity | GO:0002892 | 4 | 0.017 | |
| lysosome organization | GO:0007040 | 21 | 0.017 | |
| drug catabolic process | GO:0042737 | 2 | 0.017 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.017 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.017 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.017 | |
| cation homeostasis | GO:0055080 | 212 | 0.017 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.017 | |
| glutamine family amino acid biosynthetic process | GO:0009084 | 2 | 0.017 | |
| single fertilization | GO:0007338 | 82 | 0.017 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.017 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.017 | |
| regeneration | GO:0031099 | 38 | 0.016 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.016 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.016 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.016 | |
| rna interference | GO:0016246 | 2 | 0.016 | |
| response to xenobiotic stimulus | GO:0009410 | 13 | 0.016 | |
| protein tetramerization | GO:0051262 | 23 | 0.016 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.016 | |
| organic heteropentacyclic compound metabolic process | GO:1901376 | 1 | 0.016 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.016 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.016 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.016 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.016 | |
| insulin secretion involved in cellular response to glucose stimulus | GO:0035773 | 36 | 0.016 | |
| cholesterol import | GO:0070508 | 2 | 0.016 | |
| gliogenesis | GO:0042063 | 141 | 0.016 | |
| regulation of immunoglobulin mediated immune response | GO:0002889 | 37 | 0.016 | |
| renal system development | GO:0072001 | 225 | 0.016 | |
| inclusion body assembly | GO:0070841 | 3 | 0.016 | |
| protein localization to organelle | GO:0033365 | 185 | 0.016 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.016 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.016 | |
| regulation of peroxidase activity | GO:2000468 | 1 | 0.016 | |
| dopamine catabolic process | GO:0042420 | 4 | 0.016 | |
| tricarboxylic acid metabolic process | GO:0072350 | 5 | 0.016 | |
| hexose metabolic process | GO:0019318 | 98 | 0.015 | |
| response to nitrosative stress | GO:0051409 | 1 | 0.015 | |
| pyridine containing compound metabolic process | GO:0072524 | 14 | 0.015 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.015 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.015 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.015 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.015 | |
| cell recognition | GO:0008037 | 83 | 0.015 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.015 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.015 | |
| negative regulation of oxidoreductase activity | GO:0051354 | 4 | 0.015 | |
| nuclear import | GO:0051170 | 95 | 0.015 | |
| complement activation | GO:0006956 | 16 | 0.015 | |
| membrane depolarization | GO:0051899 | 64 | 0.015 | |
| dna metabolic process | GO:0006259 | 303 | 0.015 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.015 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.015 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.015 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.015 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.015 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.014 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.014 | |
| myosin filament assembly | GO:0031034 | 2 | 0.014 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.014 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.014 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.014 | |
| hatching | GO:0035188 | 4 | 0.014 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i | GO:0019885 | 3 | 0.014 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.014 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.014 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.014 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.014 | |
| respiratory tube development | GO:0030323 | 167 | 0.014 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.014 | |
| negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000151 | 1 | 0.014 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.014 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.014 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.014 | |
| stem cell differentiation | GO:0048863 | 268 | 0.014 | |
| positive regulation of b cell mediated immunity | GO:0002714 | 26 | 0.014 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.014 | |
| cholesterol transport | GO:0030301 | 38 | 0.014 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.014 | |
| hormone metabolic process | GO:0042445 | 86 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| palate development | GO:0060021 | 76 | 0.014 | |
| drug metabolic process | GO:0017144 | 4 | 0.014 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.014 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.013 | |
| positive regulation of protein localization to cell surface | GO:2000010 | 2 | 0.013 | |
| regulation of hypersensitivity | GO:0002883 | 10 | 0.013 | |
| transition metal ion transport | GO:0000041 | 38 | 0.013 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.013 | |
| fibrinolysis | GO:0042730 | 3 | 0.013 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.013 | |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.013 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.013 | |
| cellular respiration | GO:0045333 | 38 | 0.013 | |
| response to heat | GO:0009408 | 27 | 0.013 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.013 | |
| bone resorption | GO:0045453 | 38 | 0.013 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.013 | |
| tissue homeostasis | GO:0001894 | 115 | 0.013 | |
| peroxisome organization | GO:0007031 | 7 | 0.013 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.013 | |
| heme metabolic process | GO:0042168 | 16 | 0.013 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.013 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.013 | |
| canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | GO:0061310 | 1 | 0.013 | |
| regulation of protein processing | GO:0070613 | 96 | 0.013 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.013 | |
| pyridine nucleotide metabolic process | GO:0019362 | 12 | 0.013 | |
| positive regulation of inflammatory response to antigenic stimulus | GO:0002863 | 11 | 0.013 | |
| intracellular protein transport | GO:0006886 | 204 | 0.013 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.013 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.013 | |
| inflammatory response to antigenic stimulus | GO:0002437 | 30 | 0.012 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.012 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.012 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.012 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.012 | |
| acute inflammatory response | GO:0002526 | 41 | 0.012 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.012 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.012 | |
| phospholipid transport | GO:0015914 | 21 | 0.012 | |
| sperm motility | GO:0030317 | 47 | 0.012 | |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.012 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.012 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.012 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.012 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.012 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.012 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.012 | |
| response to oxygen levels | GO:0070482 | 62 | 0.012 | |
| regulation of monocyte chemotactic protein 1 production | GO:0071637 | 1 | 0.012 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.012 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.012 | |
| citrulline metabolic process | GO:0000052 | 3 | 0.012 | |
| nadp metabolic process | GO:0006739 | 6 | 0.012 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.012 | |
| muscle tissue development | GO:0060537 | 308 | 0.012 | |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.012 | |